Financial Advisor Sponsor:Dean L. Boebinger |
Bookmark this site!
(Enter Stock Symbol)
Partner Sites
AnnuitiesWall Street Journal
eHealthInsurance
Fund Mojo on Facebook
Fund Mojo help you discover the best fund managers, funds, and related information
Fund Intelligence | Best Managers | SHSCX Insights | SHSCX Score | SHSCX Performance | SHSCX Manager | SHSCX News | SHSCX Allocation | SHSCX Holdings Change
Fund Intelligence | Best Managers | SHSCX Insights | SHSCX Score | SHSCX Performance | SHSCX Manager | SHSCX News | SHSCX Allocation | SHSCX Holdings Change
Mutual Fund Insights: BlackRock Health Sciences Ops Inv C Fund (SHSCX)
In-depth Analysis of BlackRock Health Sciences Ops Inv C Fund (SHSCX)
6 months 1 year 3 year 5 year |
-
Last Trade: $27.68 on 3/19/2010, Change: +0.01 (0.04%)
Fund Manager - Thomas P. Callan
Fund Manager Tenure: 5.1 years [Similar Funds: SHSAX SHSPX SHSSX ]Fundmojo Fund Grade: A+ (Score: 0.82) (What does this score mean?)Callan, CFA, managing director and senior portfolio manager, is head of BlackRock's Global Opportunities equity team. He is architect of the team's investment process, leads the team's Investment Strategy Group, and provides portfolio and risk management oversight for all of the team's products. Prior to joining BlackRock in 1996, Callan was with the PNC Asset Mgmt Group, which he joined in 1992. Callan earned a BA degree in economics, with honors, from Boston College in 1981. Get more insights on Thomas P. Callan
What we like about BlackRock Health Sciences Ops Inv C Fund (SHSCX)
Data for BlackRock Health Sciences Ops Inv C Fund (SHSCX) as of January 31, 2010
- BlackRock Health Sciences Ops Inv C Fund (SHSCX) management has been with BlackRock Health Sciences Ops Inv C Fund for 5.1 years
- BlackRock Health Sciences Ops Inv C Fund (SHSCX) has good short-term performance (1-year return 26.13% vs 24.07% Health category average)
- BlackRock Health Sciences Ops Inv C Fund (SHSCX) has good mid-term performance (3-year return 5.05% vs -0.24% Health category average)
- BlackRock Health Sciences Ops Inv C Fund (SHSCX) has good Long-term performance (5-year return 9.34% vs 4.22% Health category average)
- BlackRock Health Sciences Ops Inv C Fund (SHSCX) ratio of up-years vs down years is greater than 2
- BlackRock Health Sciences Ops Inv C Fund (SHSCX) has a Morningstar rating of 4 and above
- BlackRock Health Sciences Ops Inv C Fund (SHSCX) is less volatile than its peers as it has a 3-year Standard Deviation of 15.65, lower than category average of 18.84
What we are cautious about BlackRock Health Sciences Ops Inv C Fund (SHSCX)
Data for BlackRock Health Sciences Ops Inv C Fund (SHSCX) as of January 31, 2010
- BlackRock Health Sciences Ops Inv C Fund (SHSCX) has an annual stock turnover rate of 153.00% that is higher than the Health average of 152.72%. This could mean BlackRock Health Sciences Ops Inv C is more nimble, but also signal potential high tax impact and high trading fees
- BlackRock Health Sciences Ops Inv C Fund (SHSCX) has a higher management fee of 2.08% than its Health average of 1.91%
- BlackRock Health Sciences Ops Inv C Fund (SHSCX) carries a 1% load
Interested in other top mutual funds in similar Health category?
Below are some additional Health mutual funds generated out of our database
- Fidelity Select Pharmaceuticals (FPHAX) [ Compare with BlackRock Health Sciences Ops Inv C Fund (SHSCX) ]
- Jennison Health Sciences Z (PHSZX) [ Compare with BlackRock Health Sciences Ops Inv C Fund (SHSCX) ]
- T. Rowe Price Health Sciences (PRHSX) [ Compare with BlackRock Health Sciences Ops Inv C Fund (SHSCX) ]
- See top fund managers for Health Category Funds
- Browse other funds in Health Category
BlackRock Health Sciences Ops Inv C Fund (SHSCX) Net Asset
Track net asset change of BlackRock Health Sciences Ops Inv C fund (SHSCX)
| Date | Net Asset |
| 01/2010 | $275.97M |
| 11/2009 | $261.74M |
| 10/2009 | $246.46M |
BlackRock Health Sciences Ops Inv C Fund (SHSCX) Portfolio Allocation
Track portfolio allocation change of BlackRock Health Sciences Ops Inv C fund (SHSCX)
| Date | Cash | Stock | Bond | Other |
| 09/2009 | 1.49% | 98.51% | 0% | 0% |
| 06/2009 | 6.7% | 93.3% | 0% | 0% |
| 03/2009 | 0.19% | 98.87% | 0% | 0.94% |
Most Recent Top 10 Holdings in BlackRock Health Sciences Ops Inv C Fund (SHSCX)
Discover what BlackRock Health Sciences Ops Inv C Fund (SHSCX) manager is buying
PFIZER INC [3.75%] Roche Holding AG [3.14%] Amgen Inc. [2.98%] JOHNSON AND JOHNS DC [2.72%] BRISTOL-MYERS SQUIBB [2.66%] Novartis [2.54%] ABBOTT LABORATORIES [2.51%] MEDCOHEALTH SOLUTNS [2.47%] COVIDIEN PLC [2.39%] | WYETH [6.27%] CVS CAREMARK CP [3.95%] WELLPOINT INC. [3.93%] ALCON INC [3.37%] PFIZER INC [3.14%] Amgen Inc. [2.77%] MEDCOHEALTH SOLUTNS [2.71%] Roche Holding AG [2.54%] BECTON DICKINSON CO [2.5%] | Amgen Inc. [5.82%] MEDCOHEALTH SOLUTNS [4.41%] Gilead Sciences, Inc. [4.22%] BECTON DICKINSON CO [4.08%] ABBOTT LABORATORIES [3.98%] CVS CAREMARK CP [3.83%] JOHNSON AND JOHNS DC [3.48%] PFIZER INC [3.2%] ALCON INC [2.94%] |
Related books and products to BlackRock Health Sciences Ops Inv C Fund (SHSCX)
Latest News on BlackRock Health Sciences Ops Inv C (SHSCX)
See what is happening with BlackRock Health Sciences Ops Inv C Fund (SHSCX)
Books and Resources
 
 
See more information on BlackRock Health Sciences Ops Inv C Fund (SHSCX)
- BlackRock Health Sciences Ops Inv C Fund Insights
- BlackRock Health Sciences Ops Inv C Fund Performance Data
- BlackRock Health Sciences Ops Inv C Fund News
- BlackRock Health Sciences Ops Inv C Fund Score Explaination
- BlackRock Health Sciences Ops Inv C Fund Manager Information
- Historic BlackRock Health Sciences Ops Inv C Fund Asset Allocation Report
- Historic BlackRock Health Sciences Ops Inv C Fund Top 10 Holding Tracking
- Historic BlackRock Health Sciences Ops Inv C Fund Asset Under Management Tracking


